CryoPort, Inc. (CYRX) to Release Quarterly Earnings on Thursday

CryoPort, Inc. (NASDAQ:CYRX) is scheduled to issue its quarterly earnings data after the market closes on Thursday, November 2nd. Analysts expect the company to announce earnings of ($0.08) per share for the quarter.

CryoPort (NASDAQ:CYRX) last released its earnings results on Tuesday, August 8th. The company reported ($0.08) earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of ($0.09) by $0.01. CryoPort had a negative net margin of 102.89% and a negative return on equity of 67.75%. The business had revenue of $2.92 million during the quarter, compared to analyst estimates of $2.84 million. On average, analysts expect CryoPort to post $-0.31 EPS for the current fiscal year and $-0.23 EPS for the next fiscal year.

Shares of CryoPort, Inc. (CYRX) opened at 7.85 on Wednesday. CryoPort, Inc. has a 12-month low of $1.96 and a 12-month high of $10.40. The stock’s 50 day moving average is $8.73 and its 200-day moving average is $5.96. The stock’s market cap is $193.69 million.

A number of research analysts have recently weighed in on CYRX shares. Needham & Company LLC raised their price target on CryoPort from $8.50 to $10.00 and gave the company a “buy” rating in a research report on Wednesday, August 30th. Janney Montgomery Scott started coverage on CryoPort in a research report on Wednesday, July 12th. They issued a “buy” rating and a $8.00 price target for the company. Finally, Cowen and Company restated an “outperform” rating and issued a $11.00 price target (up previously from $7.50) on shares of CryoPort in a research report on Tuesday, September 12th.

TRADEMARK VIOLATION WARNING: This piece was originally posted by Sports Perspectives and is owned by of Sports Perspectives. If you are viewing this piece on another domain, it was stolen and republished in violation of United States & international trademark & copyright law. The correct version of this piece can be accessed at

A hedge fund recently raised its stake in CryoPort stock. Northern Trust Corp grew its position in CryoPort, Inc. (NASDAQ:CYRX) by 105.0% in the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 22,179 shares of the company’s stock after buying an additional 11,358 shares during the quarter. Northern Trust Corp owned 0.09% of CryoPort worth $109,000 at the end of the most recent quarter. Hedge funds and other institutional investors own 12.10% of the company’s stock.

About CryoPort

Cryoport, Inc (Cryoport) is a provider of cryogenic logistics solutions to the life sciences industry through its purpose-built packaging, information technology and specialized cold chain logistics expertise. The Company provides logistics solutions for biologic materials, such as immunotherapies, stem cells, chimeric antigen receptors (CAR)-T cells, and reproductive cells for clients.

Receive News & Ratings for CryoPort Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CryoPort Inc. and related companies with's FREE daily email newsletter.

Latest News

Leave a Reply